No Data
No Data
BTIG Maintains Bionano Genomics(BNGO.US) With Buy Rating, Maintains Target Price $2
Buy Rating Affirmed for BioNano Genomics Amidst Operational Progress and Strategic Financial Planning
Bionano Genomics, Inc. (BNGO) Canaccord Genuity 44th Annual Growth Conference (Transcript)
Bionano Genomics (BNGO) Upgraded to Buy: Here's Why
Maxim Group Reaffirms Their Hold Rating on BioNano Genomics (BNGO)
Express News | Bionano Expects 2024 Revenue Of $36M-$40M (Prior $37M-$41M) Vs. $38.08M Consensus; Sees Q3 Revenue Of $7.9-$8.9M Vs. $10.09M Consensus
No Data
2786 OP : Uptrend coming !!![+1 👍](https://static.moomoo.com/nnq/emoji/static/image/img-apple-64/1f44d-1f3fb.png)
![+1 👍](https://static.moomoo.com/nnq/emoji/static/image/img-apple-64/1f44d-1f3fb.png)
![+1 👍](https://static.moomoo.com/nnq/emoji/static/image/img-apple-64/1f44d-1f3fb.png)